LOGIN  |  REGISTER
Surmodics

Aesthetic Medical (NASDAQ: AIH) Stock Quote

Last Trade: US$0.46 0.06 14.50
Volume: 92,062
5-Day Change: 22.89%
YTD Change: -33.58%
Market Cap: US$21.780M

Latest News From Aesthetic Medical

SHENZHEN, China, April 18, 2024 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its annual report for the fiscal year of 2023 after the U.S. market closes on Thursday, April 25, 2024. About Aesthetic Medical International Holdings Group Limited AIH, known as... Read More
SHENZHEN, China, March 08, 2024 (GLOBE NEWSWIRE) - - Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will request a hearing before the Nasdaq Hearings Panel as the next step in the process in seeking an extension to satisfy the minimum bid price requirement set forth in Nasdaq Listing Rule... Read More
Shenzhen, China, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced (1) the appointment of Onestop Assurance PAC as the Company’s independent registered public accounting firm to replace Union Power HK CPA Limited (“Union Power”), effective December 12, 2023; (2) the resignation... Read More
SHENZHEN, China, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced that it has received a notification letter (the “Notification Letter”) from the Nasdaq Stock Market LLC (the “Nasdaq”) dated September 6, 2023, notifying the Company that it is not in compliance with the minimum... Read More
SHENZHEN, China, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the six months ended June 30, 2023. Mr. ZHANG Chen, the Chairman of the Company, commented, “On August 16, 2023, I was honored to be elected as the Chairman of AIH. This was a... Read More
Closing of Share Transfer, Issue of Conversion Shares, and Issue of Warrants SHENZHEN, China, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “ Company ” or “ AIH ”), a leading provider of aesthetic medical services in China, is pleased to announce further to its Previous Disclosure, the Company has closed its previously announced (i) Share Transfer of an aggregate... Read More
SHENZHEN, China, May 17, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, announced its unaudited financial results for the three months ended March 31, 2023. Dr. Pengwu Zhou, the Chairman and CEO of the Company, commented, “The end of 2022 to the beginning of 2023 was a period of widespread... Read More
SHENZHEN, China, May 11, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its unaudited financial results for the first quarter of 2023 before the U.S. market opens on Wednesday, May 17, 2023. The Company will host a conference call to discuss the Company’s... Read More
SHENZHEN, China, April 14, 2023 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), a leading provider of aesthetic medical services in China, today announced that it will release its annual report for the fiscal year of 2022 before the U.S. market opens on Friday, April 21, 2023. The Company will host a conference call to discuss the Company’s financial... Read More
C4 Therapeutics

COPYRIGHT ©2023 HEALTH STOCKS HUB